MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock
11:44 EDT 1 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
MOUNTAIN VIEW, Calif., Aug. 1, 2012 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced the pricing of an underwritten public offering of 3,880,598 shares of its common stock at a price of $13.40 per share to the public. ...
Other Sources for this Article
More From BioPortfolio on "MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
